Started day 2 of #NANETS22 at 7 AM to meet my wonder colleagues from Canada and US. Ecstatic to work with eminent experts like Dr Simron Singh and Dr Lisa Bodei on our international NCTN RCT. #NETRETREAT PRRT re-treatment post progression. Stay tuned!!

My dear friend Aman Chauhan doing an excellent discussion on PRRT retreatment! NET RETREAT trial coming soon! #NANETS2022 NANETS #CCTG and SWOG Cancer Research Network collaboration NCI CTEP Clinical Research #LetsTalkAboutNETs

New sign to promote our ⁦QCRI Queen's⁩ public education event! Come join us ⁦Queen's University⁩ ⁦Queen's Health Sciences⁩ ⁦Queen's UniversityResearch⁩ supported by ⁦Gairdner Foundation⁩

#ASTRO22 Do patients w #breastcancer w low 21-gene RS need regional node irradiation to lower locoregional recurrence risk? #RxPONDER data suggest only a randomized trial devoted to this question can give a decisive answer. #TAILOR -RT #NCIC MA-39 #bcsm swog.org/news-events/ne…

Under the leadership of Dr. Robert B. Montgomery, UW Medicine / Fred Hutchinson Cancer Center opened and enrolled its first #prostatecancer patient to the phase 3 DASL-HiCaP (NCT04136353) clinicaltrials.gov/ct2/show/NCT04…

A 9-4
DYNAMIC-III/CO.29
Goal to⬇️toxicity in ctDNA (-) where risk is lower BUT
⬆️ intensity of chemo in ctDNA (+) where risk of recurrence is highest.

Tx intensity uses a ladder based on what patient/physician choose would be their standard choice
#CRCTrialsChat 2/3

Fantastic 2-day Colorectal Memorial Sloan Kettering Cancer Center CME, I encourage all interested to attend, live or virtual. I’ll be joining in person to present our NEO #organsparing results. Julio Garcia Aguilar Dr. Carl J Brown 🌎 Chiles Research Institute CCTG Manju George MVSc PhD Rectal cancer Survivor OncoAlert

DYNAMIC III is one of two North American trials to define the role of #ctDNA guided management of NODE ➕ colon cancer. Kudos to CCTG Jonathan Loree 🇨🇦 Jeanne Tie Sharlene Gill, MD, MPH, MBA for contributing to this global effort. Chiles Research Institute SWOG Cancer Research Network

#CCTG PAC4 Not all pancreatic cysts are cancerous, but once discovered, they should be watched. This trial aims to compare 2 approaches for monitoring cysts that may help decrease the number of surgical procedures performed & help improve the early detection of #PancreaticCancer .

#CCTG is seeking an outstanding visionary cancer trialist for the position of Senior Investigator - with expertise in cancer clinical trial methods & conduct to be part of an internationally recognized research team.
For more information & how to apply >
ctg.queensu.ca/public/careers…

Updated📢 Management of toxicities from #immunotherapy : ESMO Clinical Practice Guideline for diagnosis, treatment & follow-up. W/ recommended assessment & tx algorithms according to grade of toxicity
ow.ly/K5nw50LcQyE
John Haanen Wolfgang Wick 🇪🇺🇺🇦 Solange Peters Marie Kostine

#SELECT RCT is activated. Utilization of innovative imaging technology to define the future of precise radiation therapy for oropharyngeal cancer. CCTG John De Almeida James Bates Steven

Excited to activate the #SELECT trial #CCTGHN11 NCICancerTrials CCTG NRG Oncology. For patients with oropharyngeal cancers not crossing midline, can lymphatic mapping (SPECT-CT) guide neck radiotherapy? Co-chair Ali Hosni NRG co-chairs: Steven James Bates

Our colleagues at CCTG just opened #CCTG HN11 SELECT trial, comparing the effectiveness of standard radiotherapy target volume to personalized radiotherapy target volume selection guided by the lymphatic mapping technique. Read more: ow.ly/arx550Lc4ar